CMS Gets Pushback For Playing Doctor In Renal Stenting Coverage Proposal
This article was originally published in The Gray Sheet
Executive Summary
Stent manufacturers are urging CMS to finalize its draft coverage decision for renal stenting, though one aspect of the proposal has some wondering whether the agency is going too far in controlling physicians' interactions with patients